-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
Blog
Cancer Moonshot's Commitment to Learning from All Patients
Mar 17, 2023
As an advocate myself, I am invigorated to hear of the recent reignition of Cancer Moonshot to end cancer as we know it. An initiative that originally was launched in 2016 with aims to accelerate scientific discovery in cancer, foster greater collaboration, and improve the sharing of data. Initial funding for Moonshot came from an authorized $1.8 billion line item within the 21st Century Cures Act.
This past month, President Biden announced a reignition of the Cancer Moonshot highlighting new goals: to reduce the death rate from cancer by at least 50 percent over the next 25 years and improve the experience of people and their families living with and surviving cancer—and, by doing these and more, to end cancer as we know it today.
As real-world evidence and health data experts, we are energized by the priority actions pledged by government. We are most excited about the prioritization in learning from all patients.
An excerpt from the official White House report:
“Today, we know cancer as a disease in which we don’t learn from the experiences of most patients. We can turn our cancer care system into a learning system. When asked, most people with cancer are glad to make their data available for research to help future patients, if it can be done easily while respecting their privacy. Additionally, the diverse personal experiences of patients and their families make their input essential in developing approaches to end cancer as we know it.”
We agree that what is essential in order for patients to want to contribute their invaluable insights, time, and data is making an experience easy and intuitive and that a safe and secure environment is upheld.
Our team is proud to be partners with numerous oncology patient advocacy organizations investing in learning from all patients through direct-to-patient health data platforms—harnessing the power of real-world data to accelerate the pace of new therapies and improve health care quality and patient outcomes.
If you would like to learn more about the current state of oncology, please visit our 2021 IQVIA Institute Global Oncology Trends Report.
More details on Cancer Moonshot can be found here.